Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
181.30
-0.68 (-0.37%)
At close: Dec 5, 2025, 4:00 PM EST
181.20
-0.10 (-0.06%)
After-hours: Dec 5, 2025, 7:40 PM EST
Biogen Stock Forecast
Stock Price Forecast
The 21 analysts with 12-month price forecasts for Biogen stock have an average target of 176.48, with a low estimate of 115 and a high estimate of 255. The average target predicts a decrease of -2.66% from the current stock price of 181.30.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock from 23 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 6 | 6 |
| Buy | 6 | 6 | 6 | 5 | 5 | 4 |
| Hold | 16 | 16 | 16 | 16 | 14 | 13 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 27 | 27 | 27 | 27 | 25 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Reiterates $118 → $157 | Hold | Reiterates | $118 → $157 | -13.40% | Nov 21, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $144 → $202 | Hold → Strong Buy | Upgrades | $144 → $202 | +11.42% | Nov 6, 2025 |
| Bernstein | Bernstein | Hold Maintains $155 → $157 | Hold | Maintains | $155 → $157 | -13.40% | Nov 3, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $217 → $210 | Buy | Maintains | $217 → $210 | +15.83% | Oct 31, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $144 → $149 | Hold | Maintains | $144 → $149 | -17.82% | Oct 10, 2025 |
Financial Forecast
Revenue This Year
10.03B
from 9.68B
Increased by 3.61%
Revenue Next Year
9.49B
from 10.03B
Decreased by -5.33%
EPS This Year
15.19
from 11.18
Increased by 35.84%
EPS Next Year
15.36
from 15.19
Increased by 1.14%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.6B | 10.3B | ||||
| Avg | 10.0B | 9.5B | ||||
| Low | 9.5B | 8.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.9% | 2.9% | ||||
| Avg | 3.6% | -5.3% | ||||
| Low | -1.7% | -16.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.91 | 17.98 | ||||
| Avg | 15.19 | 15.36 | ||||
| Low | 14.32 | 10.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 42.3% | 18.4% | ||||
| Avg | 35.8% | 1.1% | ||||
| Low | 28.1% | -29.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.